Correlation of Pancreatic Islet Morphology with Postprandial Glucose Tolerance in Subjects Undergoing Pancreatic Resection for Islet Cell Tumors

Overview

About this study

Determine the effect of endocrine pancreas morphology, turnover and dedifferentiation on glucose tolerance in humans.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Any patients undergoing pancreatic surgical resection for the following diagnoses:
- Non-functioning neuroendocrine tumor
- Insulinoma

Exclusion Criteria:

Pre-operatively confirmed malignancies such as ductal adenocarcinoma or metastatic neuroendocrine disease.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Adrian Vella, M.D.	Open for enrollment	Contact information: Paula Giesler R.N. (507)255-8345 Giesler.Paula@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Adrian Vella, M.D.

Open for enrollment

Contact information:

Paula Giesler R.N.

(507)255-8345

Giesler.Paula@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials